GREGORY BELL: Open Payments
NPI 1467953026 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,115 in 112 payments from 15 companies in 2025. Trend: 2023 $1,491 · 2024 $1,649 · 2025 $2,115
Food & beverage: $2,030Education: $85
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $288 |
| Lilly USA, LLC | 18 | $268 |
| UCB, Inc. | 19 | $258 |
| Galderma Laboratories, L.P. | 4 | $240 |
| LEO Pharma Inc. | 10 | $196 |
| ABBVIE INC. | 15 | $192 |
| Janssen Biotech, Inc. | 12 | $169 |
| Regeneron Healthcare Solutions, Inc. | 5 | $159 |
| PFIZER INC. | 6 | $105 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
Products named: TALTZ, NEMLUVIO, DUPIXENT, Bimzelx, ILUMYA, TREMFYA, ADBRY, SKYRIZI.
Industry payments across AR — which companies pay providers there.
